Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/10/2025

Recommended Dosing of Panax Ginseng for Fatigue Management

Effective Dosing Regimen

  • Higher doses of Panax ginseng (2,000-3,000 mg per day) have demonstrated significantly improved fatigue severity in clinical trials 1, 2, 3
  • Lower doses (400 mg twice daily) have been shown to be ineffective at improving fatigue 1, 4
  • Twice-daily dosing is preferred, with administration in the morning and before noon to avoid potential sleep disruption 5
  • Duration of treatment should be at least 8-16 weeks, as shorter intervention periods (29 days or 4 weeks) did not show significant improvement in fatigue 1, 2, 3

Evidence from Clinical Trials

  • A trial using American ginseng (Panax quinquefolius) at 1,000 mg twice daily (2,000 mg total) showed significant improvement in fatigue as measured by the MFSI-SF scale (p=0.003) 1, 2, 3
  • Korean red ginseng (Panax ginseng C.A. Meyer) at 1,000 mg twice daily significantly reduced cancer-related fatigue at 8 weeks (p=0.013) and 16 weeks (p=0.019) 2, 4
  • Fermented red ginseng extract at 3,000 mg daily for 60 days significantly lowered fatigue scores compared to usual care (p<0.01) 2, 3

Special Considerations

  • The American Society of Clinical Oncology (ASCO) conditionally recommends American ginseng at a dose of 2,000 mg daily for managing cancer-related fatigue in adults undergoing cancer treatment 5
  • Different preparations of ginseng (American, Korean, fermented) have shown varying degrees of efficacy 1, 2, 3

Clinical Application Algorithm

  • Start with 2,000 mg daily (1,000 mg twice daily) of standardized Panax ginseng extract 1, 2, 5
  • Administer in divided doses, preferably in the morning and before noon 5
  • Continue treatment for at least 8-16 weeks for optimal benefit 1, 2, 3
  • If inadequate response after 8 weeks, consider increasing to 3,000 mg daily if well tolerated 2, 3